3Bugt R. Irinotecan in the treatment of gastric cancer[J]. Annals of Oncology, 2003,14 (2): 37.
二级参考文献25
1[1]Alberts SR, Cervantes A, van de Velde CJH. Gastric cancer:Epidemiology, pathology and treatment. Annals of Oncology,2003, 14 (Suppl 2) :ii31
2[2]Frederick LG, David LP, Irvin DF, et al. AJCC Cancer Staging Manual. 6th. ed, New York: Springer, 2002, 99
3[3]Hundahl SA, Menck HR, Mansour EG, et al. The national cancer database report on gastric carcinoma. Cancer, 1997, 80: 2333
4[4]Spataro V, Genoni M, Maurer C, et al. Stomach cancer: 10years' experience with surgical treatment and possibilities for improving the prognosis. Helv Chir Acta, 1993, 59:589
5[5]Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 2001, 345:725
6[6]Bajetta E, Buzzoni R, Mariani E, et al. Adjuvant chemotherapy in gastric cancer: 5 - year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology, 2002, 13:299
7[7]Falcone A. Future strategies and adjuvant treatment of gastric cancer. Annals of Oncology, 2003, 14 (Suppl 2) :ii45
8[8]Roth AD, Allal AS, Brundler MA, et al. Neoadjuvant radiochemotherapy for locally advanced gastric cancer: A phase Ⅰ -Ⅱ study. Annals of Oncology, 2003, 14:110
9[9]Newman E, Marcus SG, Potmesil M, et al. Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer. J Gastrointest Surg, 2002 6 (2) :212 (discussion 223)
10[10]Gimelius B, Ekstrom K, Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Annals of Oncology, 1997, 8:1
7Pinto C,Di Fabio F,Siena S,et al.PhaseⅡstudy of cetuximab incombination with FOLFIRI in patients with untreated advanced gastricor gastroesophageal junction adenocarcinoma (folcetux study)Annals of Oncology,2007.
8Bang YJ,Van Cutsem E,Feyereislova A,et al.Trastuzumab in com-bination with chemotherapy versus chemotherapy alone for treatment ofHER2-positive advanced gastric or gastro-oesophageal junctioncancer (ToGA):a phase 3,open-label,randomised controlled trialThe Lancet,2010.
9Van Cutsem E,Moiseyenko VM,Tjulandin S,et al.Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study GroupJournal of Clinical Oncology,2006.
